Capricor Therapeutics (CAPR) Stock Price, Quote, News & History | Benzinga

SPY761.26−0.26%QQQ707.87−0.27%BTC/USD—DIA518.00−0.21%GLD381.40−0.16%TLT80.06+0.01%

Capricor Therapeutics Inc (CAPR) Stock Price, Quote, News & History

CAPRNASDAQ

Trade with Public

Trade with Public

$6.71

-0.56-7.7%

Last update: Oct 16, 7:50 PM

$6.79

-0.48-6.6%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.21

Close

$6.71

Volume / Avg.

1.95M / 6.86M

Day Range

$6.68 - $7.25

52 Wk Range

2.96 - 40.37

Market Cap

$394.79M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

31

Short Interest

35.75%

Days to Cover

4.52

Recent Capricor Therapeutics, Inc. News

What's Going On With Capricor Therapeutics Stock Monday?

Capricor Therapeutics (CAPR) shares top-line HOPE-3 extension data for Deramiocel in DMD ahead of its Nov 22 FDA PDUFA date.

Vandana Singh

Capricor Therapeutics Stock Surges: What's Going On?

Shares of Capricor Therapeutics Inc. (NASDAQ: CAPR) are trading higher Wednesday morning following the release of positive long-term clinical data for its lead cellular therapy.

Henry Khederian

Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a Vultr AI rack order.

Avi Kapoor

Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIvf led gainers at 187.2%, while Silexion fell 16.6%.

Avi Kapoor

Yext Posts Upbeat Q2 Earnings, Joins Fervo Energy, MiniMed Group And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Nasdaq Composite falling around 1% on Tuesday. Shares of Yext Inc (NYSE:YEXT) rose sharply after the company reported better-than-expected second-quarter earnings. The company also

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-104.00M

Investing Cash Flow (TTM)

-144.36M

Financing Cash Flow (TTM)

246.05M

Free Cash Flow (TTM)

-129.78M

Capital Expenditure (TTM)

-25.78M

Net Change in Cash (TTM)

-2.31M

Analyst Trends and Forecast

1

May

3

Jul

1

Aug

2

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$243.22M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.71

Earnings Yield % (TTM)

-33.75%

Earnings Yield % (FWD)

-28.51%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.24

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$20.94M

Debt to Equity

0.37

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-